Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02600884 · ClinicalTrials.gov registry record · NA
Efficacy Trial of a Brief Parent-Based Adolescent Sexual Health Intervention
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 1,183
- Enrollment target
NCT02600884: Completed NA study, sponsored by The University of Texas Health Science Center, Houston.
NCT02600884 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 1,183 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (16% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02600884, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,183 participants
- Enrollment target
Study Summary
The purpose of this research study is to evaluate a brief parent-based adolescent sexual health intervention called Families Talking Together Plus (FTT+). FTT+ is based on an established intervention called Families Talking Together (FTT) and will enhance FTT by adding modules on human papillomavirus (HPV). The goal of the study is to evaluate whether FTT will help parents increase sexual health communication, delay adolescent sexual debut, and increase HPV vaccination. FTT will be delivered to parents of minority youth and will be delivered by student nurses.
Primary Outcome
The FTT + HPV survey is a survey that has been developed by the investigator for this study. The survey is administered at baseline, 1, and 6 months using iPads and is available as Audio Computer-Assisted Self-Interviews in both English and Spanish.
Interventions
- BEHAVIORAL Families Talking Together Plus (FTT+HPV)
- BEHAVIORAL Brief motivational interviewing (BMI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,183 participants |
| Start Date | 2015-09 |
| Est. Completion | 2019-04 |
| Phase | NA |
What the finished NCT02600884 record still lists
NCT02600884 is an interventional study that assigns participants to a tested intervention. Its 1,183 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (16% lower).
The record links to 0 conditions, and to 2 interventions - of which Families Talking Together Plus (FTT+HPV) is the first listed.
NCT02600884 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02600884 about?
NCT02600884 is a clinical study titled "Efficacy Trial of a Brief Parent-Based Adolescent Sexual Health Intervention". The purpose of this research study is to evaluate a brief parent-based adolescent sexual health intervention called Families Talking Together Plus (FTT+). FTT+ is based on an established intervention called Families Talking Together (FTT) and will enhance FTT by adding modules on human papillomaviru...
What is the current status of trial NCT02600884?
This trial is currently completed. It is a NA study. The enrollment target is 1,183 participants. The study started on 2015-09. Estimated completion is 2019-04.
What interventions are being tested in trial NCT02600884?
The interventions under investigation include: Families Talking Together Plus (FTT+HPV) (BEHAVIORAL), Brief motivational interviewing (BMI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02600884?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02600884's enrollment target sits among peer trials
1,183 89th of 2000 higher than 1,912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07286058 · 1,182 participants · Phase 3
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- NCT04293562 · 1,186 participants · Phase 3
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- NCT05580419 · 1,188 participants · NA
Impact of 4PCP on Practitioner and Patient Outcomes
- NCT06290869 · 1,188 participants · Phase 3
Tobacco Education and Lung Health Study (TEAL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia